Symbol="VBLT"
AssetType="Common Stock"
Name="Vascular Biogenics Ltd"
Description="Vascular Biogenics Ltd., a clinical biopharmaceutical company, focuses on the discovery, development and commercialization of cancer treatments and immune / inflammatory indications. The company is headquartered in Modi'in, Israel."
CIK="1603207"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="HASATAT 8 ST., MODI'IN,, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="21361500"
EBITDA="-24601500"
PERatio="None"
PEGRatio="0"
BookValue="0.285"
DividendPerShare="0"
DividendYield="0"
EPS="-0.32"
RevenuePerShareTTM="0.007"
ProfitMargin="0"
OperatingMarginTTM="-46.95"
ReturnOnAssetsTTM="-0.379"
ReturnOnEquityTTM="-0.782"
RevenueTTM="545000"
GrossProfitTTM="554000"
DilutedEPSTTM="-0.32"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="9.63"
PriceToBookRatio="0.354"
EVToRevenue="133.64"
EVToEBITDA="0.482"
Beta="0.718"
num_52WeekHigh="2.131"
num_52WeekLow="0.101"
num_50DayMovingAverage="0.226"
num_200DayMovingAverage="0.168"
SharesOutstanding="70500000"
DividendDate="None"
ExDividendDate="None"
symbol="VBLT"
open="0.31"
high="0.31"
low="0.28"
price="0.29"
volume="1244730.00"
latest_trading_day="2023-07-14"
previous_close="0.31"
change="-0.02"
change_percent="-5.0339%"
aroon_positive_momentum_days="99"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="99"
Volume_recent_avg="3284931"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="-0.29"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="99"
Aroon_momentum_negative="1"
image_negative_thumbnail_id_1="1094"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_negative_thumbnail_id_2="140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0036.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="579"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0020.jpeg"
image_positive_thumbnail_id_1="697"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_positive_thumbnail_id_2="622"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
